The shareholders of Diamyd Medical AB (OM:DIAM B) authorized a share repurchase program at its Annual General Meeting on December 7, 2011. Under the program, the company will purchase series B shares on NASDAQ OMX Stockholm. The maximum number of shares repurchased shall be such that Diamyd Medical shares held in treasury from time to time do not exceed 5% of all shares in Diamyd Medical. Repurchase of shares must be conducted in accordance with the Stock Exchange's Rule Book for Issuers. The purpose of the authorization is to give the Board a tool to optimize the capital structure of the company in order to create increased value for the shareholders. The repurchase program will expire at the conclusion of the company's next Annual General Meeting. As of November 7, 2011, the company has 1,437,876 Series A shares and 28,141,257 Series B shares.

Diamyd Medical AB's share repurchase program expired on December 6, 2012. No repurchases were made.